187 related articles for article (PubMed ID: 2060529)
1. Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Dannemann BR; McCutchan JA; Israelski DM; Antoniskis D; Leport C; Luft BJ; Chiu J; Vildé JL; Nussbaum JN; Orellana M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):193-5. PubMed ID: 2060529
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
Katlama C
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
Foppa CU; Bini T; Gregis G; Lazzarin A; Esposito R; Moroni M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):187-9. PubMed ID: 2060526
[TBL] [Abstract][Full Text] [Related]
5. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
[TBL] [Abstract][Full Text] [Related]
6. Clinical programs for clinical research on AIDS: description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection.
Jacobson MA; Besch CL; Child C; Hafner R; Muth K; Deyton L
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):195-8. PubMed ID: 1676364
[TBL] [Abstract][Full Text] [Related]
7. Treatment of toxoplasmic encephalitis with intravenous clindamycin.
Dannemann BR; Israelski DM; Remington JS
Arch Intern Med; 1988 Nov; 148(11):2477-82. PubMed ID: 3190380
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
[TBL] [Abstract][Full Text] [Related]
9. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
Araujo FG; Suzuki Y; Remington JS
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
[TBL] [Abstract][Full Text] [Related]
10. Role of clindamycin in the treatment of central nervous system toxoplasmosis.
Rolston KV; Hoy J
Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590
[TBL] [Abstract][Full Text] [Related]
11. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.
Antinori A; Ammassari A; Maiuro G; Camilli G; Damiano F; Federico G; Pizzigallo E; Tamburrini E
Ital J Neurol Sci; 1992 Sep; 13(6):475-9. PubMed ID: 1428784
[TBL] [Abstract][Full Text] [Related]
13. AIDS commentary. Toxoplasmic encephalitis.
Luft BJ; Remington JS
J Infect Dis; 1988 Jan; 157(1):1-6. PubMed ID: 3121758
[No Abstract] [Full Text] [Related]
14. Toxoplasmic encephalitis.
Luft BJ; Hafner R
AIDS; 1990 Jun; 4(6):593-5. PubMed ID: 2386623
[No Abstract] [Full Text] [Related]
15. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Simon DI; Brosius FC; Rothstein DM
Arch Intern Med; 1990 Nov; 150(11):2379-84. PubMed ID: 2241449
[TBL] [Abstract][Full Text] [Related]
16. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
[TBL] [Abstract][Full Text] [Related]
18. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.
Leport C; Bastuji-Garin S; Perronne C; Salmon D; Marche C; Briçaire F; Vilde JL
J Infect Dis; 1989 Sep; 160(3):557-8. PubMed ID: 2760509
[No Abstract] [Full Text] [Related]
19. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Wei HX; Wei SS; Lindsay DS; Peng HJ
PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
[TBL] [Abstract][Full Text] [Related]
20. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.
Ruf B; Pohle HD
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):183-6. PubMed ID: 2060525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
